Literature DB >> 5837102

Lithocholic acid in human-blood serum.

J B Carey, G Williams.   

Abstract

Lithocholic acid was present in the serum of three patients with, jaundice and, in smaller amounts, in two healthy adults. This bile acid occurs naturally in human feces but induces cirrhosis of the liver when fed to a wide variety of experimental animals. The finding of lithocholic acid in blood is of interest because of its possible role in injuring human liver.

Entities:  

Mesh:

Substances:

Year:  1965        PMID: 5837102     DOI: 10.1126/science.150.3696.620

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  6 in total

1.  Identification of bile acids in the serum and urine in cholestasis. Evidence for 6alpha-hydroxylation of bile acids in man.

Authors:  J A Summerfield; B H Billing; C H Shackleton
Journal:  Biochem J       Date:  1976-02-15       Impact factor: 3.857

2.  Production of bile duct hyperplasia and gallstones by lithocholic acid.

Authors:  R H Palmer; Z Ruban
Journal:  J Clin Invest       Date:  1966-08       Impact factor: 14.808

3.  Anemia with spur cells: a red cell defect acquired in serum and modified in the circulation.

Authors:  R A Cooper
Journal:  J Clin Invest       Date:  1969-10       Impact factor: 14.808

4.  Serum bile acids in primary biliary cirrhosis.

Authors:  G M Murphy; A Ross; B H Billing
Journal:  Gut       Date:  1972-03       Impact factor: 23.059

5.  An analysis of lipoproteins, bile acids, and red cell membranes associated with target cells and spur cells in patients with liver disease.

Authors:  R A Cooper; M Diloy Puray; P Lando; M S Greenverg
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

Review 6.  Inflammatory pseudo-tumor of the liver: a rare pathological entity.

Authors:  Walid Faraj; Hana Ajouz; Deborah Mukherji; Gerald Kealy; Ali Shamseddine; Mohamed Khalife
Journal:  World J Surg Oncol       Date:  2011-01-23       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.